Avid Bioservices (CDMO) Short Interest Ratio & Short Volume $12.36 0.00 (0.00%) (As of 12/17/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Avid Bioservices Short Interest DataAvid Bioservices (CDMO) has a short interest of 11.64 million shares. This marks a -0.68% decrease in short interest from the previous month. The short interest ratio (days to cover) is 6.3, indicating that it would take 6.3 days of the average trading volume of 1.32 million shares to cover all short positions.Current Short Interest11,640,000 sharesPrevious Short Interest11,720,000 sharesChange Vs. Previous Month-0.68%Dollar Volume Sold Short$142.94 millionShort Interest Ratio6.3 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares63,963,000 sharesPercentage of Shares Shorted18.20%Today's Trading Volume713,401 sharesAverage Trading Volume1,323,165 sharesToday's Volume Vs. Average54% Short Selling Avid Bioservices? Sign up to receive the latest short interest report for Avid Bioservices and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCDMO Short Interest Over TimeCDMO Days to Cover Over TimeCDMO Percentage of Float Shorted Over Time Ad Wall Street StarHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still simple, proof-of-concept systems. For its next act, AI is going to help save lives. Already better than humans at a number of medical tasks, AI is ramping up to completely revolutionize healthcare.Click here to learn more about the booming eHealth industry - and see which microcap will be at the Avid Bioservices Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/202411,640,000 shares $142.94 million -0.7%N/A6.3 $12.28 11/15/202411,720,000 shares $142.28 million -13.3%N/A6.5 $12.14 10/31/202413,510,000 shares $134.56 million +2.4%N/A9.8 $9.96 10/15/202413,190,000 shares $135.46 million +3.7%N/A15.7 $10.27 9/30/202412,720,000 shares $144.75 million +1.1%N/A13.1 $11.38 9/15/202412,580,000 shares $140.39 million -2.9%N/A12.5 $11.16 Get the Latest News and Ratings for CDMO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Avid Bioservices and its competitors with MarketBeat's FREE daily newsletter. 8/31/202412,950,000 shares $136.49 million +0.6%N/A12.5 $10.54 8/15/202412,870,000 shares $137.45 million -7.6%N/A12.9 $10.68 7/31/202413,930,000 shares $145.43 million +13.2%N/A12.9 $10.44 7/15/202412,310,000 shares $102.42 million -0.4%N/A11.1 $8.32 6/30/202412,360,000 shares $88.25 million -18.0%N/A12.2 $7.14 6/15/202415,080,000 shares $106.84 million +31.0%N/A14.6 $7.09 5/31/202411,510,000 shares $93.12 million -3.0%N/A10.6 $8.09 5/15/202411,860,000 shares $109.71 million +7.2%N/A8.5 $9.25 4/30/202411,060,000 shares $84.39 million +7.2%N/A8 $7.63 4/15/202410,320,000 shares $70.18 million +2.1%N/A7.8 $6.80 3/31/202410,110,000 shares $67.74 million -6.7%N/A7.6 $6.70 3/15/202410,840,000 shares $68.18 million +64.5%N/A8 $6.29 2/29/20246,590,000 shares $50.61 million +16.6%N/A4 $7.68 2/15/20245,650,000 shares $43.51 million +8.0%N/A3.8 $7.70 1/31/20245,230,000 shares $35.41 million -5.6%N/A3.6 $6.77 1/15/20245,540,000 shares $34.85 million -2.0%N/A3.9 $6.29 12/31/20235,650,000 shares $36.73 million -20.9%N/A4.1 $6.50 12/15/20237,140,000 shares $43.70 million +2.3%N/A5.5 $6.12 11/30/20236,980,000 shares $35.53 million +14.2%N/A7.3 $5.09 11/15/20236,110,000 shares $32.08 million +13.4%N/A8.6 $5.25 10/31/20235,390,000 shares $33.15 million +6.9%N/A8.8 $6.15 10/15/20235,040,000 shares $41.48 million -2.0%N/A8.7 $8.23 9/30/20235,140,000 shares $48.52 million -2.8%N/A9.2 $9.44 9/15/20235,290,000 shares $55.07 million +1.5%N/A9.3 $10.41 8/31/20235,210,000 shares $61.48 million +2.6%N/A8.5 $11.80 8/15/20235,080,000 shares $65.23 million -1.7%N/A9.1 $12.84 7/31/20235,170,000 shares $65.45 million -6.0%N/A8.8 $12.66 7/15/20235,500,000 shares $72.77 million -1.6%N/A9.8 $13.23 6/30/20235,590,000 shares $78.09 million -7.3%N/A10.1 $13.97 6/15/20236,030,000 shares $102.39 million -0.7%N/A10.9 $16.98 5/31/20236,070,000 shares $93.78 million +0.5%N/A10.3 $15.45 5/15/20236,040,000 shares $106.91 million +14.8%N/A10.2 $17.70 4/30/20235,260,000 shares $94.94 million No ChangeN/A9.2 $18.05 4/15/20235,260,000 shares $103.41 million +5.4%N/A9 $19.66URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin 3/31/20234,990,000 shares $93.61 million -14.0%N/A8.4 $18.76 3/15/20235,800,000 shares $101.33 million +22.6%N/A10 $17.47 2/28/20234,730,000 shares $77.86 million -2.9%N/A8.8 $16.46 2/15/20234,870,000 shares $82.35 million -11.3%N/A8.9 $16.91 1/31/20235,490,000 shares $86.91 million +6.0%N/A9.5 $15.83 1/15/20235,180,000 shares $84.49 million +2.8%N/A8.3 $16.31 12/30/20225,040,000 shares $69.40 million +6.3%N/A7.8 $13.77 12/15/20224,740,000 shares $65.13 million -5.8%N/A7 $13.74 11/30/20225,030,000 shares $78.77 million +0.8%N/A7.5 $15.66 11/15/20224,990,000 shares $78.04 million +2.7%N/A7.9 $15.64 10/31/20224,860,000 shares $82.33 million No ChangeN/A7.8 $16.94 10/15/20224,860,000 shares $85.78 million -10.2%N/A8.2 $17.65 9/30/20225,410,000 shares $103.44 million +14.1%N/A9.3 $19.12 9/15/20224,740,000 shares $90.77 million -3.3%N/A8.2 $19.15 8/31/20224,900,000 shares $84.38 million -6.8%N/A8.7 $17.22 8/15/20225,260,000 shares $103.83 million -10.1%N/A9.1 $19.74 7/31/20225,850,000 shares $114.95 million +3.9%N/A9 $19.65 7/15/20225,630,000 shares $101.90 million +2.9%N/A8.2 $18.10 6/30/20225,470,000 shares $83.47 million -7.8%N/A8.3 $15.26 6/15/20225,930,000 shares $74.54 million -0.8%10.8%9.2 $12.57 5/31/20225,980,000 shares $79.95 million +5.1%N/A9.4 $13.37 5/15/20225,690,000 shares $71.24 million -7.3%N/A9 $12.52 4/30/20226,140,000 shares $82.64 million +14.3%N/A10.3 $13.46 4/15/20225,370,000 shares $98.32 million +3.5%N/A9.3 $18.31 3/31/20225,190,000 shares $105.72 million -5.0%N/A8.8 $20.37 3/15/20225,460,000 shares $106.25 million -6.4%N/A9.4 $19.46 2/28/20225,830,000 shares $119.40 million -3.3%N/A8.9 $20.48 2/15/20226,030,000 shares $129.65 million +2.2%N/A8.9 $21.50 1/31/20225,900,000 shares $111.33 million +7.5%N/A8.8 $18.87 1/15/20225,490,000 shares $115.13 million -6.3%N/A5.4 $20.97 12/31/20215,860,000 shares $170.99 million -5.9%N/A5.9 $29.18 12/15/20216,230,000 shares $159.99 million +7.2%N/A6.3 $25.68 11/30/20215,810,000 shares $177.55 million -5.8%N/A6 $30.56 11/15/20216,170,000 shares $200.59 million +15.1%N/A6.7 $32.51 10/29/20215,360,000 shares $164.44 million +7.2%N/A6 $30.68 10/15/20215,000,000 shares $128.95 million -2.3%N/A8.4 $25.79 9/30/20215,120,000 shares $110.44 million +11.1%N/A9.9 $21.57 9/15/20214,610,000 shares $87.82 million +0.4%N/A8.1 $19.05 8/31/20214,590,000 shares $111.26 million +2.0%N/A7.8 $24.24 8/13/20214,500,000 shares $112.91 million -6.1%7.4%7.5 $25.09 7/30/20214,790,000 shares $122.86 million -2.0%7.9%8.2 $25.65 7/15/20214,890,000 shares $126.60 million +0.8%8.1%8.5 $25.89 6/30/20214,850,000 shares $124.40 million +24.4%8.0%8.4 $25.65 6/15/20213,900,000 shares $92.86 million +3.2%6.5%7.3 $23.81 5/28/20213,780,000 shares $80.44 million -5.3%6.3%6.9 $21.28 5/14/20213,990,000 shares $76.93 million +3.9%6.6%5.6 $19.28 4/30/20213,840,000 shares $83.52 million +3.2%6.4%5.2 $21.75 4/15/20213,720,000 shares $71.54 million +2.5%6.2%4.7 $19.23 3/31/20213,630,000 shares $61.93 million -4.7%6.0%4.5 $17.06 3/15/20213,810,000 shares $65.99 million +82.3%7.2%4.9 $17.32Is the Trump/Musk duo good for shares of TSLA? (Ad)If you held shares of Tesla throughout 2024, you know It’s been a year of extreme highs and lows… But according to our one expert, new yearly highs are on the horizon… In his words, Tesla is building momentum like in 2020, especially as Trump supports the EV maker. Which is why we’re emailing you now… You see, most people will simply buy shares of Tesla ahead of the election… But as they say “There is more than one way to skin a cat” In fact, we’ve found another way to play shares of Tesla.Discover how to trade Tesla, simply follow this link here. 2/26/20212,090,000 shares $39.61 million +4.0%3.5%2.8 $18.95 2/12/20212,010,000 shares $34.81 million -8.6%3.3%3.5 $17.32 1/29/20212,200,000 shares $31.00 million +1.9%3.7%4.1 $14.09 1/15/20212,160,000 shares $30.67 million No Change3.6%4.5 $14.20 1/15/20202,630,000 shares $17.20 million +14.9%N/A7.1 $6.54 12/31/20192,290,000 shares $17.54 million -8.8%N/A6.4 $7.66 CDMO Short Interest - Frequently Asked Questions What is Avid Bioservices' current short interest? Short interest is the volume of Avid Bioservices shares that have been sold short but have not yet been closed out or covered. As of November 30th, investors have sold 11,640,000 shares of CDMO short. Learn More on Avid Bioservices' current short interest. What is a good short interest ratio for Avid Bioservices? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CDMO shares currently have a short interest ratio of 6.0. Learn More on Avid Bioservices's short interest ratio. Which institutional investors are shorting Avid Bioservices? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Avid Bioservices: Wolverine Trading LLC, Wolverine Asset Management LLC, and Belvedere Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Avid Bioservices' short interest increasing or decreasing? Avid Bioservices saw a drop in short interest in the month of November. As of November 30th, there was short interest totaling 11,640,000 shares, a drop of 0.7% from the previous total of 11,720,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Avid Bioservices' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Avid Bioservices: Xenon Pharmaceuticals Inc. (3.78%), Amicus Therapeutics, Inc. (6.97%), Merus (12.74%), ACADIA Pharmaceuticals Inc. (5.96%), MorphoSys AG (0.09%), Zai Lab Limited (4.76%), Vera Therapeutics, Inc. (13.29%), Bausch Health Companies Inc. (3.53%), Arrowhead Pharmaceuticals, Inc. (8.09%), Dyne Therapeutics, Inc. (10.17%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short Avid Bioservices stock? Short selling CDMO is an investing strategy that aims to generate trading profit from Avid Bioservices as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Avid Bioservices? A short squeeze for Avid Bioservices occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CDMO, which in turn drives the price of the stock up even further. How often is Avid Bioservices' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CDMO, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies XENE Short Interest Data FOLD Short Interest Data MRUS Short Interest Data ACAD Short Interest Data MOR Short Interest Data ZLAB Short Interest Data VERA Short Interest Data BHC Short Interest Data ARWR Short Interest Data DYN Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CDMO) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersTrump’s Secret Manhattan ProjectOn January 20, a whole new Manhattan Project is set to begin: Trump’s Manhattan Project. Folks, I just s...Banyan Hill Publishing | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | SponsoredWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Behind the Markets | SponsoredMissed Nvidia? Buy Elon Musk’s “Silent Partner”In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my f...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avid Bioservices, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avid Bioservices With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CDMO Stock Alerts